DRUG DOSING GUIDELINES IN PATIENTS WITH RENAL-FAILURE

被引:1
|
作者
SWAN, SK
BENNETT, WM
机构
来源
WESTERN JOURNAL OF MEDICINE | 1992年 / 156卷 / 06期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The metabolism and excretion of many drugs and their pharmacologically active metabolites depend on normal renal function. Accumulation and toxicity can develop rapidly if dosages are not adjusted in patients with impaired renal function. In addition, many drugs that are not dependent on the kidneys for elimination may exert untoward effects in the uremic milieu of advanced renal disease. A familiarity with basic pharmacologic principles and a systematic approach are necessary when adjusting drug dosages in patients with abnormal kidney function. The distinct steps involve calculating the patient's glomerular filtration rate, choosing and administering a loading dose, determining a maintenance dose, and a decision regarding monitoring of drug concentrations. If done properly, therapy in renal patients should achieve the desired pharmacologic effects while avoiding drug toxicity. Physicians must not oversimplify the pharmacologic complexities presented by patients with renal failure by relying excessively on nomograms and "cookbook" equations. In addition to a reduced glomerular filtration rate, patients with renal disease often have alterations in pharmacokinetics such as bioavailability, protein binding, hepatic biotransformation, and volume of distribution. An awareness of biologically active or toxic metabolites of parent compounds that accumulate when the glomerular filtration rate is reduced is also necessary to avoid toxicity. The effects of dialysis on drug elimination and the need for supplemental dosing are additional considerations in patients undergoing renal replacement therapy.
引用
收藏
页码:633 / 638
页数:6
相关论文
共 50 条
  • [1] DRUG PRESCRIBING IN RENAL-FAILURE - DOSING GUIDELINES FOR ADULTS
    BENNETT, WM
    ARONOFF, GR
    MORRISON, G
    GOLPER, TA
    PULLIAM, J
    WOLFSON, M
    SINGER, I
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1983, 3 (03) : 155 - 193
  • [2] GUIDELINES FOR DRUG-THERAPY IN RENAL-FAILURE
    BENNETT, WM
    SINGER, I
    GOLPER, T
    FEIG, P
    COGGINS, CJ
    ANNALS OF INTERNAL MEDICINE, 1977, 86 (06) : 754 - 783
  • [3] ANTIBIOTIC DOSING IN RENAL-FAILURE
    MADERAZO, EG
    MEDICAL CLINICS OF NORTH AMERICA, 1995, 79 (04) : 919 - &
  • [4] Dosing guidelines for fluconazole in patients with renal failure
    Cousin, L
    Le Berre, M
    Launay-Vacher, V
    Izzedine, H
    Deray, G
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (11) : 2227 - 2231
  • [5] DRUG PRESCRIBING FOR PATIENTS IN RENAL-FAILURE
    ANDERSON, RJ
    HOSPITAL PRACTICE, 1983, 18 (02): : 145 - &
  • [6] DRUG PHARMACOKINETICS IN PATIENTS WITH RENAL-FAILURE
    FRANSON, TR
    SORENSEN, ET
    ILLINOIS MEDICAL JOURNAL, 1978, 153 (02): : 111 - 116
  • [7] COMPUTERIZED DRUG DOSING IN RENAL-FAILURE - REAL PROBLEM AND A PRACTICAL SOLUTION
    GREENBURG, AG
    ADACHI, W
    MCCLURE, DK
    LAWHEAD, RA
    PESKIN, GW
    JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1978, 18 (05): : 308 - 316
  • [8] DRUG IN RENAL-FAILURE
    DRINOVEC, J
    ZDRAVSTVENI VESTNIK, 1985, 54 (05): : 209 - 212
  • [9] DRUG-TREATMENT IN PATIENTS WITH RENAL-FAILURE
    MERTZ, DP
    MEDIZINISCHE KLINIK, 1980, 75 (16) : 12 - 17
  • [10] DRUG-THERAPY FOR PATIENTS IN RENAL-FAILURE
    BARCLAY, WR
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1977, 237 (24): : 2635 - 2635